Annual Genotoxic Impurities Summit

This premier B2B event provides the appropriate platform to engage and discuss ideas with your peers, while facilitating a professional atmosphere and environment for good company representation and development.

The summit will shed light on the implementation of recent updates to the ICH M7 guidelines in regard to genotoxic impurities.

It is an honour and privilege to invite you to participate in this Summit. We look forward to welcoming you in Vienna this coming June!

Key Practical Learning Points of the Summit:

  • Successful step-by-step experience on the implementation of recent updates in ICH M7
  • Regulatory and practical scientific considerations for efficient genotoxic impurity identification and control

Who Should Attend:

Chief Executives, Directors, Vice Presidents, Department Heads, Leaders and Managers specialising in:

  • Research and Development
  • Drug Discovery
  • Drug Development
  • Drug Design
  • Analitical Science
  • Chromatography
  • Mass Spectrometry
  • Spectroscopy
  • LC-MS
  • Purification
  • Formulation
  • Assay Development
  • Microscopy
  • Chemistry (analytical, organic, medicinal, protein)
  • GMP
  • Good Laboratory Practice
  • Technology transfer
  • Validation
  • Qualty assuarance
  • Quality control
  • Quality by Design (QbD)
  • Regulatory
  • Toxicology
  • Genotoxin
  • Genotoxicology
  • Impurities
  • Genotoxic impurities
Media partners